Selective cognitive and psychiatric manifestations in Wolfram Syndrome

Orphanet Journal of Rare Diseases

Volumn 10, Issue 1, 2015, Pages

  Bischoff, Allison N ^a   Reiersen, Angela M ^a   Buttlaire, Anna ^a   Al Lozi, Amal ^a   Doty, Tasha ^a   Marshall, Bess A ^a   Hershey, Tamara ^a   Austin, P ^b   Earhart, G ^b   Eisenstein, S ^b   Hoekel, J ^b   Tychsen, L ^b   Hullar, T ^b   Karzon, R ^b   Manwaring, L ^b   Paciorkowski, A R ^b   Pepino De Gruev, Y ^b   Pickett, K ^b   Shimony, J ^b   Viehoever, A ^b   White, N H ^b   Urano, F ^b   Ranck, S ^b   Beato, B ^b   Bihun, E ^b   Koller, J M ^b   Lugar, H M ^b   Rutlin, J ^b   Semenkovich, K ^b   more..

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Behavior; Cognition; Development; Diabetes mellitus; Psychiatry; Wolfram syndrome

Indexed keywords

ATOMOXETINE; DULOXETINE; FLUOXETINE; GLUCOSE; HEMOGLOBIN A1C; LISDEXAMFETAMINE; LORAZEPAM; RISPERIDONE; SERTRALINE;

ADOLESCENT; ADULT; AGE; ANXIETY DISORDER; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY ASSESSMENT; DISRUPTIVE BEHAVIOR; ETHNICITY; FEMALE; GENDER; GENERALIZED ANXIETY DISORDER; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPULSIVENESS; INSULIN DEPENDENT DIABETES MELLITUS; INTELLIGENCE; MAJOR DEPRESSION; MALE; MEMORY; OBSESSIVE COMPULSIVE DISORDER; ODOR RECOGNITION TEST; PEDIATRIC SLEEP QUESTIONNAIRE; PHOBIA; QUESTIONNAIRE; SEPARATION ANXIETY; SLEEP DISORDER; SLEEP QUALITY; SOMNOLENCE; TASK PERFORMANCE; THINKING; UNIVERSITY OF PENNSYLVANIA SMELL IDENTIFICATION TEST; UNSPECIFIED ANXIETY DISORDER; UNSPECIFIED BIPOLAR DISORDER; UNSTRUCTURED INTERVIEW; WOLFRAM SYNDROME; WOLFRAM UNIFIED RATING SCALE; YOUNG ADULT; COGNITION; ODOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ADOLESCENT; ADULT; CHILD; COGNITION; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INTELLIGENCE; MALE; MEMORY; SMELL; WOLFRAM SYNDROME; YOUNG ADULT;

EID: 84930626494     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/s13023-015-0282-1     Document Type: Article

References (45)

1. Wolfram DJ. Diabetes mellitus and simple optic atrophy among siblings: report of four cases. Mayo Clin Proc. 1938;9:715-8.
2. Takeda K, Inoue H, Tanizawa Y, Matsuzaki Y, Oba J, Watanabe Y, et al. WFS1 (Wolfram Syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet. 2001;10(5):477-84.
3. Ishihara H, Takeda S, Tamura A, Takahashi R, Yamaguchi S, Takei D, et al. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet. 2004;13(11):1159-70.
4. Yamada T, Ishihara H, Tamura A, Takahashi R, Yamaguchi S, Takei D, et al. WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Hum Mol Genet. 2006;15(10):1600-9.
5. Akiyama M, Hatanaka M, Ohta Y, Ueda K, Yanai A, Uehara Y, et al. Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice. Diabetologia. 2009;52(4):653-63.
6. Yamamoto H, Hofmann S, Hamasaki D, Yamamoto H, Kreczmanski P, Schmitz C, et al. Wolfram Syndrome 1 (WFS1) protein expression in retinal ganglion cells and optic nerve glia of the cynomolgus monkey. Exp Eye Res. 2006;83(5):1303-6.
7. Lu S, Kanekura K, Hara T, Mahadevan J, Spears LD, Oslowski CM, et al. A calcium-dependent protease as a potential therapeutic target for Wolfram Syndrome. Proc Natl Acad Sci. 2014;111(49):E5292-301.
8. Hershey T, Lugar HM, Shimony JS, Rutlin J, Koller JM, Perantie DC, et al. Early brain vulnerability in Wolfram Syndrome. PLoS One. 2012;7(7):e40604.
9. Pickett KA, Duncan RP, Hoekel J, Marshall D, Hershey T, Earhart G, et al. Early presentation of gait impairment in Wolfram Syndrome. Orphanet J Rare Dis. 2012;7(1):92.
10. Marshall BA, Permutt MA, Paciorkowski AR, Hoekel J, Karzon R, Wasson J, et al. Phenotypic characteristics of early Wolfram Syndrome. Orphanet J Rare Dis. 2013;8(1):64.
11. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) Syndrome. Lancet. 1995;346:1458-63.
12. Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, Mkadem SA, Chabrol B, et al. Neurologic features and genotype-phenotype correlation in Wolfram Syndrome. Ann Neurol. 2011;69(3):501-8.
13. Nickl-Jockschat T, Kunert J, Heroertz-Dahlmann B, Grozinger M. Psychiatric symptoms in a patient with Wolfram Syndrome caused by a combination of thalamic deficit and endocrinological pathologies. Neurocase. 2008;15(1):47-52.
14. Hardy C, Khanim F, Torres R, Scott-Brown M, Seller A, Poulton J, et al. Clinical and molecular genetic analysis of 19 Wolfram Syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet. 1999;65(5):1279-90.
15. Waschbisch A, Volbers B, Struffert T, Hoyer J, Schwab S, Bardutzky J. Primary diagnosis of Wolfram Syndrome in an adult patient-case report and description of a novel pathogenic mutation. Neurol Sci. 2011;300:191-3.
16. Medlej R, Wasson J, Baz P, Azar S, Salti I, Loiselet J, et al. Diabetes mellitus and optic atrophy: a study of Wolfram Syndrome in the Lebanese population. J Clin Endocrinol Metab. 2004;89(4):1656-61.
17. Lessell S, Rosman NP. Juvenile diabetes mellitus and optic atrophy. Arch Neurol. 1977;34(12):759-65.
18. Verri A, Borutti G, Sandrini G, Poloni M, Vailati A. A case of Wolfram Syndrome: neurological features. Ital J Neurol Sci. 1982;3:351-3.
19. Nguyen C, Foster ER, Paciorkowski AR, Viehover A, Considine C, Bondurant A, et al. Reliability and validity of the Wolfram Unified Rating Scale (WURS). Orphanet J Rare Dis. 2012;7(1):89.
20. Wechsler D. Wechsler abbreviated scale of intelligence. 3rd ed. Cleveland, OH: Psychological Corporation; 1999.
21. McGrew KS, Woodcock RW. Woodcock-Johnson III technical manual. Itasca, IL: Riverside Publishing; 2001.
22. Wechsler D. Wechsler intelligence scale for children. 3rd ed. Cleveland, OH: Psychological Corporation; 1997.
23. Wechsler D. Wechsler adult intelligence scale-III. San Antonio, TX: Psychological Corporation; 1997.
24. Fridlund AJ, Delis DC. California verbal learning test-children's version. San Antonio, TX: Psychological Corporation; 1994.
25. Delis DC, Kaplan E. California verbal learning test-II. San Antonio, TX: Psychological Corporation; 2000.
26. Conners CK, Epstein JN, Angold A, Klaric J. Continuous performance test performance in a normative epidemiological sample. J Abnorm Child Psychol. 2003;31:555-62.
27. Doty RL. The smell identification test administration manual. 3rd ed. Haddon Heights, NJ: Sensonics; 1995.
28. Wechsler D. Wechsler test of adult reading: WTAR. San Antonio, TX: Psychological Corporation; 2001.
29. Gadow KD, Sprafkin J. Child symptom inventory-4 screening and norms manual. Stony Brook, NY: Checkmate Plus; 2002.
30. Gadow KD, Sprafkin J, Weiss MD. Adult self-report-4 manual. Stony Brook, NY: Checkmate Plus; 2004.
31. Gadow KD, Sprafkin J. Youth's inventory-4 manual. Stony Brook, NY: Checkmate Plus; 1999.
32. Chervin RD, Hedger K, Dillon JE, Pituch KJ. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000;1:21-32.
33. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
34. Harris PA, Taylor Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatict support. J Biomed Inform. 2009;42(2):377-81.
35. Sequeira A, Kim C, Seguin M, Lesage A, Chawsky N, Desautels A, et al. Wolfram syndrome and suicide: evidence for a role of WFS1 in suicidal and impulsive behavior. Am J Med Genet B Neuropsychiatr Genet. 2003;119B(1):108-13.
36. Swift M, Swift RG. Wolframin mutations and hospitalization for psychiatric illness. Mol Psychiatry. 2005;10(8):799-803.
37. Okten A, Gedik Y, Demirci A, Mocan H, Erduran E, Aslan Y. Various clinical aspects of DIDMOAD (Wolfram) Syndrome. Turk J Pediatr. 1995;37:235-40.
38. Genís D, Davalos A, Molins A, Ferrer I. Wolfram Syndrome: a neuropathological study. Acta Neuropathol. 1997;93(4):426-9.
39. Jackson MJ, Bindoff LA, Weber K, Wilson JN, Ince P, Alberti KG, et al. Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care. 1994;17(7):728-33.
40. Strous RD, Shoenfeld Y. To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev. 2006;6(1):54-60.
41. Matyka KA, Crawford C, Wiggs L, Dunger DB, Stores G. Alterations in sleep physiology in young children with insulin-dependent diabetes mellitus: relationship to nocturnal hypoglycemia. J Pediatr. 2000;137(2):233-8.
42. Estrada CL, Danielson KK, Drum ML, Lipton RB. Insufficient sleep in young patients with diabetes and their families. Biol Res Nurs. 2012;14(1):48-54.
43. Perfect MM, Patel PG, Scott RE, Wheeler MD, Patel C, Griffin K, et al. Sleep, glucose, and daytime functioning in youth with type 1 diabetes. Sleep. 2012;35(1):81-8.
44. Caruso NC, Radovanovic B, Kennedy D, Couper J, Kohler M, Kavanagh PS, et al. Sleep, executive functioning and behaviour in children and adolescents with type 1 diabetes. Sleep Med. 2014;15(12):1490-9.
45. Colavito V, Tesoriero C, Wirtu AT, Grassi-Zucconi G, Bentivoglio M. Limbic thalamus and state-dependent behavior: the paraventricular nucleus of the thalamic midline as a node in circadian timing and sleep/wake-regulatory networks. Neurosci Biobehav Rev. 2014. http://www.sciencedirect.com/science/article/pii/S014976341400325X.